-+ 0.00%
-+ 0.00%
-+ 0.00%

Catalyst Pharma To Showcase Real‑World Findings In Duchenne Muscular Dystrophy Through Multiple Poster Presentations At 2026 MDA Clinical & Scientific Conference

Benzinga·03/06/2026 13:09:05
Listen to the news

Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that the Company will showcase real‑world findings in Duchenne muscular dystrophy (DMD) through multiple poster presentations at the 2026 MDA Clinical & Scientific Conference in Orlando, Florida. Catalyst will also sponsor a vamorolone-focused MDA Industry Forum with Santhera Pharmaceuticals.